{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:37:00Z","timestamp":1788878220216,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["FK 01KG1601"],"award-info":[{"award-number":["FK 01KG1601"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12906-018-2266-x","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T06:10:49Z","timestamp":1530598249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Reducing antibiotic use for uncomplicated urinary tract infection in general practice by treatment with uva-ursi (REGATTA) \u2013 a double-blind, randomized, controlled comparative effectiveness trial"],"prefix":"10.1186","volume":"18","author":[{"given":"Kambiz","family":"Afshar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Fleischmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Schmiemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Bleidorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hummers-Pradier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Friede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Wegscheider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildik\u00f3","family":"G\u00e1gyor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"key":"2266_CR1","doi-asserted-by":"publisher","first-page":"b5633","DOI":"10.1136\/bmj.b5633","volume":"340","author":"P Little","year":"2010","unstructured":"Little P, Merriman R, Turner S, Rumsby K, Warner G, Lowes JA, et al. Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study. BMJ. 2010;340:b5633. \n                    https:\/\/doi.org\/10.1136\/bmj.b5633\n                    \n                  .","journal-title":"BMJ"},{"key":"2266_CR2","doi-asserted-by":"publisher","first-page":"c199","DOI":"10.1136\/bmj.c199","volume":"340","author":"P Little","year":"2010","unstructured":"Little P, Moore MV, Turner S, Rumsby K, Warner G, Lowes JA, et al. Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ. 2010;340:c199. \n                    https:\/\/doi.org\/10.1136\/bmj.c199\n                    \n                  .","journal-title":"BMJ"},{"key":"2266_CR3","first-page":"729","volume":"52","author":"TCM Christiaens","year":"2002","unstructured":"Christiaens TCM, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract. 2002;52:729\u201334.","journal-title":"Br J Gen Pract"},{"key":"2266_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1741-7015-8-30","volume":"8","author":"J Bleidorn","year":"2010","unstructured":"Bleidorn J, Gagyor I, Kochen MM, Wegscheider K, Hummers-Pradier E. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trial. BMC Med. 2010;8:30. \n                    https:\/\/doi.org\/10.1186\/1741-7015-8-30\n                    \n                  .","journal-title":"BMC Med"},{"key":"2266_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1471-2296-14-71","volume":"14","author":"BJ Knottnerus","year":"2013","unstructured":"Knottnerus BJ, Geerlings SE, van Charante EP, ter Riet G. Women with symptoms of uncomplicated urinary tract infection are often willing to delay antibiotic treatment: a prospective cohort study. BMC Fam Pract. 2013;14:71. \n                    https:\/\/doi.org\/10.1186\/1471-2296-14-71\n                    \n                  .","journal-title":"BMC Fam Pract"},{"key":"2266_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/jac\/dkn230","volume":"62","author":"DSY Ong","year":"2008","unstructured":"Ong DSY, Kuyvenhoven MM, van Dijk L, Verheij TJM. Antibiotics for respiratory, ear and urinary tract disorders and consistency among GPs. J Antimicrob Chemother. 2008;62:587\u201392. \n                    https:\/\/doi.org\/10.1093\/jac\/dkn230\n                    \n                  .","journal-title":"J Antimicrob Chemother"},{"key":"2266_CR7","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1056\/NEJMp1311479","volume":"369","author":"A Hollis","year":"2013","unstructured":"Hollis A, Ahmed Z. Preserving antibiotics, rationally. N Engl J Med. 2013;369:2474\u20136. \n                    https:\/\/doi.org\/10.1056\/NEJMp1311479\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"2266_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1047-2797(00)00072-7","volume":"10","author":"B Foxman","year":"2000","unstructured":"Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10:509\u201315.","journal-title":"Ann Epidemiol"},{"key":"2266_CR9","doi-asserted-by":"publisher","first-page":"c279","DOI":"10.1136\/bmj.c279","volume":"340","author":"GM Leydon","year":"2010","unstructured":"Leydon GM, Turner S, Smith H, Little P. Women\u2019s views about management and cause of urinary tract infection: qualitative interview study. BMJ. 2010;340:c279. \n                    https:\/\/doi.org\/10.1136\/bmj.c279\n                    \n                  .","journal-title":"BMJ"},{"key":"2266_CR10","doi-asserted-by":"publisher","first-page":"h6544","DOI":"10.1136\/bmj.h6544","volume":"351","author":"I G\u00e1gyor","year":"2015","unstructured":"G\u00e1gyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. BMJ. 2015;351:h6544. \n                    https:\/\/doi.org\/10.1136\/bmj.h6544\n                    \n                  .","journal-title":"BMJ"},{"key":"2266_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1186\/s12879-014-0693-y","volume":"14","author":"I Vik","year":"2014","unstructured":"Vik I, Bollestad M, Grude N, Baerheim A, Molstad S, Bjerrum L, Lindbaek M. Ibuprofen versus mecillinam for uncomplicated cystitis--a randomized controlled trial study protocol. BMC Infect Dis. 2014;14:693. \n                    https:\/\/doi.org\/10.1186\/s12879-014-0693-y\n                    \n                  .","journal-title":"BMC Infect Dis"},{"key":"2266_CR12","volume-title":"PDR for herbal medicine","author":"J Gruenwald","year":"2007","unstructured":"Gruenwald J, Brendler T, Jaenicke C. PDR for herbal medicine. 4th ed. Montvale, NJ: Thompson Healthcare Inc.; 2007.","edition":"4"},{"key":"2266_CR13","first-page":"305","volume":"27","author":"B Kedzia","year":"1975","unstructured":"Kedzia B, Wroci\u0144ski T, Mrugasiewicz K, Gorecki P, Grzewi\u0144ska H. Przeciwbakteryjne dzia\u0142anie moczu zawierajacego produkty metabolizmu arbutyny. Med Dosw Mikrobiol. 1975;27:305\u201314.","journal-title":"Med Dosw Mikrobiol"},{"key":"2266_CR14","first-page":"1","volume-title":"Community herbal monograph on Arctostaphylos uva-ursi (L.) Spreng, folium","author":"European Medicines Agency, Committee on Herbal Medicinal Products (HMPC)","year":"2012","unstructured":"European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Community herbal monograph on Arctostaphylos uva-ursi (L.) Spreng, folium; 2012. p. 1\u20136."},{"issue":"5","key":"2266_CR15","first-page":"277","volume":"11","author":"J Albrecht","year":"1988","unstructured":"Albrecht J, Kreyes G. Langzeitbehandlung von Dauerkatheterpatienten: Chemoprophylaxe oder Phytotherapie? Extr urol. 1988;11(5):277\u201380.","journal-title":"Extr urol"},{"key":"2266_CR16","doi-asserted-by":"publisher","unstructured":"Flower A, Wang L, Lewith G, Liu JP, Li Q. Chinese herbal medicine for treating recurrent urinary tract infections in women. Cochrane Database Syst Rev. 2015;(6):CD010446. \n                    https:\/\/doi.org\/10.1002\/14651858.CD010446.pub2\n                    \n                  .","DOI":"10.1002\/14651858.CD010446.pub2"},{"key":"2266_CR17","doi-asserted-by":"publisher","first-page":"294638","DOI":"10.1155\/2012\/294638","volume":"2012","author":"S Joos","year":"2012","unstructured":"Joos S, Glassen K, Musselmann B. Herbal medicine in primary healthcare in Germany: the Patient's perspective. Evid Based Complement Alternat Med. 2012;2012:294638. \n                    https:\/\/doi.org\/10.1155\/2012\/294638\n                    \n                  .","journal-title":"Evid Based Complement Alternat Med"},{"key":"2266_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0011-393X(05)80204-8","volume":"53","author":"B Larsson","year":"1993","unstructured":"Larsson B, Jonasson A, Fianu S. Prophylactic effect of UVA-E in women with recurrent cystitis: a preliminary report. Curr Ther Res. 1993;53:441\u20133. \n                    https:\/\/doi.org\/10.1016\/S0011-393X(05)80204-8\n                    \n                  .","journal-title":"Curr Ther Res"},{"issue":"6","key":"2266_CR19","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00120-017-0389-1","volume":"56","author":"J Kranz","year":"2017","unstructured":"Kranz J, Schmidt S, Lebert C, et al. Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients: update 2017 of the interdisciplinary AWMF S3 guideline (article in German). Urologe A. 2017;56(6):746\u201358. \n                    https:\/\/doi.org\/10.1007\/s00120-017-0389-1\n                    \n                  .","journal-title":"Urologe A"},{"key":"2266_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1477-7525-3-42","volume":"3","author":"DJ Wild","year":"2005","unstructured":"Wild DJ, Clayson DJ, Keating K, Gondek K. Validation of a patient-administered questionnaire to measure the activity impairment experienced by women with uncomplicated urinary tract infection: the activity impairment assessment (AIA). Health Qual Life Outcomes. 2005;3:42.","journal-title":"Health Qual Life Outcomes"},{"key":"2266_CR21","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/sim.5634","volume":"32","author":"M Kieser","year":"2013","unstructured":"Kieser M, Friede T, Gondan M. Assessment of statistical significance and clinical relevance. Stat Med. 2013;32:1707\u201319.","journal-title":"Stat Med"},{"key":"2266_CR22","first-page":"Doc17","volume":"13","author":"J Bleidorn","year":"2015","unstructured":"Bleidorn J, Bucak S, G\u00e1gyor I, Hummers-Pradier E, Dierks M. Why do - or don't - patients with urinary tract infection participate in a clinical trial? A qualitative study in German family medicine. Ger Med Sci. 2015;13:Doc17.","journal-title":"Ger Med Sci"},{"issue":"639","key":"2266_CR23","doi-asserted-by":"publisher","first-page":"e702","DOI":"10.3399\/bjgp15X686965","volume":"65","author":"CC Butler","year":"2015","unstructured":"Butler CC, Hawking MK, Quigley A, McNulty CA. Incidence, severity, help seeking, and management of uncomplicated urinary tract infection: a population-based survey. Br J Gen Pract. 2015;65(639):e702\u20137.","journal-title":"Br J Gen Pract"},{"key":"2266_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s13063-017-2145-7","volume":"18","author":"J Trill","year":"2017","unstructured":"Trill J, Simpson C, Webley F, et al. Uva-ursi extract and ibuprofen as alternative treatments of adult female urinary tract infection (ATAFUTI): study protocol for a randomised controlled trial. Trials. 2017;18:421. \n                    https:\/\/doi.org\/10.1186\/s13063-017-2145-7\n                    \n                  .","journal-title":"Trials"},{"key":"2266_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0924-8579(98)00021-1","volume":"10","author":"MA Minassian","year":"1998","unstructured":"Minassian MA, Lewis DA, Chattopadhyay D, Bovill B, Duckworth GJ, Williams JD. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Int J Antimicrob Agents. 1998;10:39\u201347.","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 2","key":"2266_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0924-8579(03)00237-1","volume":"22","author":"B Lobel","year":"2003","unstructured":"Lobel B. Short term therapy for uncomplicated urinary tract infection today. Clinical outcome upholds the theories. Int J Antimicrob Agents. 2003;22(Suppl 2):85\u20137.","journal-title":"Int J Antimicrob Agents"},{"key":"2266_CR27","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/S0149-2918(00)86734-X","volume":"21","author":"GE Stein","year":"1999","unstructured":"Stein GE. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin Ther. 1999;21:1864\u201372. \n                    https:\/\/doi.org\/10.1016\/S0149-2918(00)86734-X\n                    \n                  .","journal-title":"Clin Ther"},{"key":"2266_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4172\/2327-4972.1000122","volume":"3","author":"J Bleidorn","year":"2014","unstructured":"Bleidorn J, K\u00f6ltzsch C, Hummers-Pradier E, G\u00e1gyor I, Theile G. Family physicians as clinical trial investigators? - a qualitative study of physicians\u2019 experiences with a double-blind clinical trial. Fam Med Med Sci Res. 2014;3:122. \n                    https:\/\/doi.org\/10.4172\/2327-4972.1000122\n                    \n                  .","journal-title":"Fam Med Med Sci Res"},{"issue":"7509","key":"2266_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/bmj.38496.452581.8F","volume":"331","author":"D Richards","year":"2005","unstructured":"Richards D, Toop L, Chambers S, Fletcher L. Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial. BMJ. 2005;331(7509):143. Epub 2005 Jun 22","journal-title":"BMJ"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-018-2266-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-018-2266-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-018-2266-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T03:42:01Z","timestamp":1569123721000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-018-2266-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2266"],"URL":"https:\/\/doi.org\/10.1186\/s12906-018-2266-x","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"22 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval has been obtained by the Independent Ethics Committees of the University Medical Center G\u00f6ttingen (No. 16\/11\/16). Informed written consent will be obtained from all participants prior to any trial-related procedures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare. Haupt Pharma Wulfing GmbH was contracted to produce and repack the trial medication (Arctuvan\u00ae). The company did not have influence on the study design and will participate neither in the clinical project management nor in the collection, analysis, and interpretation of data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"203"}}